Market news

Butterfly's growth is fueled by Embedded partnerships, strong medical school adoption, Compass AI, and a robust US government pipeline. Read more on BFLY stock here.

Butterfly Network shares are falling Wednesday, pulling back after the stock soared Tuesday on a bullish analyst initiation.

Butterfly Network (BFLY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Butterfly Network (BFLY) shares rose 22% in Tuesday trading after Needham initiated coverage with a

Butterfly Network Inc (NYSE:BFLY) shares are soaring Tuesday after Needham initiated coverage on the stock with a Buy rating and a $10 price target. Here's what you should know.

Butterfly Network (BFLY) has an average rating of buy and mean price target of $10.50, according to

See the top trending companies in healthtech

NEW YORK & BURLINGTON, Mass., September 08, 2026--Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly"), a pioneer and leader in semiconductor-based ultrasound, cloud software and AI, today announced that it will participate in the Morgan Stanley 24th Annual Global Healthcare Conference in New York City on September 15, 2026. Joseph DeVivo, President, Chief Executive Officer & Chairman; John Doherty, EVP, Chief Financial Officer; and Megan Carlson, SVP, Accounting & Finance – Chief Accounting Offic

Strong US jobs data and firm wage growth keep the focus on interest rates and the cost of capital. While large companies debate how fast to invest, smaller AI focused stocks can often move quicker and test new ideas in automation, data and machine learning. This article highlights three early stage AI small caps from our US screener that could help you think differently about long term growth. The stocks covered below are just a sample, and the full screen surfaced 26 more AI small caps with...

Butterfly Network has found a use for its ultrasound chips far beyond bedside imaging. On September 1, Merge Labs, the brain-interface startup backed by OpenAI and associated with Sam Altman, selected Butterfly Network, Inc. (NYSE:BFLY) as its exclusive ultrasound-on-chip supplier under a multiyear Butterfly Embedded agreement. The arrangement includes upfront payments, development milestones, purchase commitments, […]

BURLINGTON, Mass. & NEW YORK, September 01, 2026--Butterfly Network, Inc. ("Butterfly") (NYSE: BFLY), a pioneer and leader in semiconductor-based ultrasound, programmable cloud software and AI, and Merge Labs today announced a multi-year licensing agreement through Butterfly Embedded™. The agreement gives Merge access to Butterfly’s Poseidon Family of Ultrasound-on-Chip™ technology for the development of ultrasound-based brain-computer interfaces (BCI).

Butterfly Network (BFLY) and Merge Labs said Tuesday they have entered into a multiyear licensing ag

Purchase increases her total beneficial ownership to 691,413 shares, or 0.26% of the company, as BFLY stock has surged 527% over the past year.

Purchase increases her total beneficial ownership to 691,413 shares, or 0.26% of the company, as BFLY stock has surged 527% over the past year.

Devivo sold shares under a pre-adopted plan, while retaining a stake worth ~$74 million.

Devivo sold shares under a pre-adopted plan, while retaining a stake worth ~$74 million.

Butterfly Network (BFLY) brings ultrasound-on-a-chip to phones, improving access and outcomes. Read the latest analysis on the stock here.

BURLINGTON, Mass. & NEW YORK, August 11, 2026--Butterfly Network, Inc. ("Butterfly") (NYSE: BFLY), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, congratulates Dr. Erica Schwartz on her confirmation as director of the Centers for Disease Control and Prevention (CDC). Dr. Schwartz has served as a member of Butterfly Network's Board of Directors since 2021 and has stepped down from the Board effective August 5, 2026 in advance of assuming her ne

Butterfly Network raises its 2026 outlook as Embedded revenues surge, enterprise POCUS expands, and Home and Community Care moves toward Q4 revenues.

Butterfly Network earnings beat and guidance raise Butterfly Network (BFLY) drew investor attention after reporting record second quarter 2026 revenue of US$32.61 million and updating its outlook for the rest of the year. The company reported a loss of US$12.91 million for the quarter and US$25.59 million for the first half of 2026. Management also issued revenue guidance for the third quarter and raised full year 2026 expectations. See our latest analysis for Butterfly Network. Butterfly...

In the past quarter, Butterfly Network, Inc. reported record Q2 2026 revenue of US$32.61 million, higher gross margins, a smaller net loss of US$12.91 million, and subsequently raised both its full-year 2026 revenue outlook to US$119 million–US$123 million and its Q3 2026 guidance to US$26 million–US$30 million. An important insight is that this performance was powered by very large growth in Embedded segment revenue and multiple new partnerships, which helped the company exceed consensus...

Butterfly Network (NYSE:BFLY) reported record second-quarter revenue and raised its full-year outlook, citing growth in its Embedded business, enterprise point-of-care ultrasound sales and progress toward commercializing its home and community care offering. Revenue for the quarter ended June 30 to

Butterfly Network Inc. (NYSE: BFLY) shares are trading higher Thursday after the company reported second-quarter financial results.

Butterfly Network (BFLY) reported a Q2 adjusted loss Thursday of $0.01 per share, narrowing from a l

Moby summary of Butterfly Network, Inc.'s Q2 2026 earnings call

Butterfly Network Inc (BFLY) reports record revenue of $32.6 million, a 39% year-over-year increase, and a historic gross margin of 71%, fueled by a 439% surge in embedded revenue.

Butterfly Network (BFLY) delivered earnings and revenue surprises of +66.67% and +14.83%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Insider executed sale under Rule 10b5-1 plan for estate planning after stock surged 250% over the past year. Post-transaction holdings total $59.17 million across direct and indirect positions.

Disposition of more than 3.1 million Class B shares, executed via a Rule 10b5-1 trading plan adopted for estate planning purposes in March 2026.

Devivo executed a non-discretionary sale to cover tax withholding on vesting RSUs, retaining 7.7 million shares worth $51.3 million.

This filing details a non-discretionary sale to cover RSU tax withholding obligations.

BURLINGTON, Mass. & NEW YORK, July 16, 2026--Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly"), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, announced that it will report second quarter 2026 financial results on Thursday, July 30, 2026, at 8:00 am ET.